Cerebral nocardiosis in a patient with NHL treated with rituximab

Abstract

American Journal of HematologyVolume 82, Issue 11 p. 1033-1034 Letter to the American Journal of HematologyFree Access Cerebral nocardiosis in a patient with NHL treated with rituximab Madappa N. Kundranda, Madappa N. Kundranda Cleveland Clinic Cancer Center, Moll Pavilion at Fairview Hospital, Cleveland, OhioSearch for more papers by this authorTimothy P. Spiro, Timothy P. Spiro Cleveland Clinic Cancer Center, Moll Pavilion at Fairview Hospital, Cleveland, OhioSearch for more papers by this authorAlaa Muslimani, Alaa Muslimani Department of Medicine, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OhioSearch for more papers by this authorK.V. Gopalakrishna, K.V. Gopalakrishna Department of Infectious Disease, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OhioSearch for more papers by this authorMark J. Melaragno, Mark J. Melaragno Department of Pathology, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OhioSearch for more papers by this authorHamed A. Daw, Hamed A. Daw Cleveland Clinic Cancer Center, Moll Pavilion at Fairview Hospital, Cleveland, OhioSearch for more papers by this author Madappa N. Kundranda, Madappa N. Kundranda Cleveland Clinic Cancer Center, Moll Pavilion at Fairview Hospital, Cleveland, OhioSearch for more papers by this authorTimothy P. Spiro, Timothy P. Spiro Cleveland Clinic Cancer Center, Moll Pavilion at Fairview Hospital, Cleveland, OhioSearch for more papers by this authorAlaa Muslimani, Alaa Muslimani Department of Medicine, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OhioSearch for more papers by this authorK.V. Gopalakrishna, K.V. Gopalakrishna Department of Infectious Disease, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OhioSearch for more papers by this authorMark J. Melaragno, Mark J. Melaragno Department of Pathology, Fairview Hospital, Cleveland Clinic Health System, Cleveland, OhioSearch for more papers by this authorHamed A. Daw, Hamed A. Daw Cleveland Clinic Cancer Center, Moll Pavilion at Fairview Hospital, Cleveland, OhioSearch for more papers by this author First published: 15 August 2007 https://doi.org/10.1002/ajh.20921Citations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Czuczman MS,Grillo-Lopez AJ,White CA, et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 1999; 17: 268– 276. 2 Qazilbash MH,Qu Z,Hosing C, et al. Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia. Am J Hematol 2005; 80: 43– 45. 3 Suzan F,Ammor M,Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 2001; 345: 1000. 4 Sharma VR,Fleming DR,Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000; 96: 1184– 1186. 5 Ravindranath Y. Treatment of refractory immune cytopenias in the 21st century—How safe is rituximab? Am J Hematol 2005; 80: 92– 93. Citing Literature Volume82, Issue11November 2007Pages 1033-1034 ReferencesRelatedInformation